Evidence map›Paper›PMID 33469999›Full record

ArticleMolecular reproduction and development2021

Genome-wide chromatin occupancy of BRDT and gene expression analysis suggest transcriptional partners and specific epigenetic landscapes that regulate gene expression during spermatogenesis.

Yoon Ra Her, Li Wang, Iouri Chepelev, Marcia Manterola, Binyamin Berkovits, Kairong Cui, Keji Zhao, Debra J Wolgemuth

Open access · greenAbstract read
In one paragraph

Article in Molecular reproduction and development, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Meiotic prophase I disruption as a strategy for nonhormonal male contraception using small-molecule inhibitor JQ1.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Adverse Effects of Nicotine on Human Sperm Nuclear Proteins.The world journal of men's health · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Yoon Ra HerDepartment of Genetics & Development, Columbia University Medical Center, New York, New York, USA.
Li WangDepartment of Genetics & Development, Columbia University Medical Center, New York, New York, USA.
Iouri ChepelevSystems Biology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
Marcia ManterolaHuman Genetics Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile.
Binyamin BerkovitsDepartment of Genetics & Development, Columbia University Medical Center, New York, New York, USA.
Kairong CuiSystems Biology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
Keji ZhaoSystems Biology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
Debra J WolgemuthDepartment of Genetics & Development, Columbia University Medical Center, New York, New York, USA.ORCID 0000-0001-9346-4135
Columbia University Irving Medical Center · USNational Institutes of Health · USCincinnati Children's Hospital Medical Center · USUniversity of Chile · CL

Funding

Function of the Bromodomain Protein Brdt in SpermatogenesisR01GM081767 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WOLGEMUTH, DEBRA J. · 2008 to 2016
$2.9M
NIGMS NIH HHS R01 GM081767
6 · The paper itself

Abstract

BRDT, a member of the BET family of double bromodomain-containing proteins, is essential for spermatogenesis in the mouse and has been postulated to be a key regulator of transcription in meiotic and post-meiotic cells. To understand the function of BRDT in these processes, we first characterized the genome-wide distribution of the BRDT binding sites, in particular within gene units, by ChIP-Seq analysis of enriched fractions of pachytene spermatocytes and round spermatids. In both cell types, BRDT binding sites were mainly located in promoters, first exons, and introns of genes. BRDT binding sites in promoters overlapped with several histone modifications and histone variants associated with active transcription, and were enriched for consensus sequences for specific transcription factors, including MYB, RFX, ETS, and ELF1 in pachytene spermatocytes, and JunD, c-Jun, CRE, and RFX in round spermatids. Subsequent integration of the ChIP-seq data with available transcriptome data revealed that stage-specific gene expression programs are associated with BRDT binding to their gene promoters, with most of the BDRT-bound genes being upregulated. Gene Ontology analysis further identified unique sets of genes enriched in diverse biological processes essential for meiosis and spermiogenesis between the two cell types, suggesting distinct developmentally stage-specific functions for BRDT. Taken together, our data suggest that BRDT cooperates with different transcription factors at distinctive chromatin regions within gene units to regulate diverse downstream target genes that function in male meiosis and spermiogenesis.

Indexed as

EpigenomicsGene Expression Regulation, DevelopmentalAnimalsBinding SitesBromodomain Containing ProteinsChromatin Immunoprecipitation SequencingDNAMaleMeiosisMiceNuclear ProteinsPromoter Regions, GeneticSpermatidsSpermatogenesisTranscription FactorsBRDT protein, mouseBromodomain Containing ProteinsDNANuclear ProteinsTranscription FactorsBRDTmale meiosisspermiogenesistranscription

Identifiers

PMID33469999
PMCPMC9342626
OpenAlexW3124694388

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.